RELEVANT PUBLICATIONS

2013

Moreno-Navarrete JM, Escoté X, Ortega F, Serino M, Campbell M, Michalski MC, Laville M, Xifra G, Luche E, Domingo P, Sabater M, Pardo G, Waget A, Salvador J, Giralt M, Rodriguez-Hermosa JI, Camps M, Kolditz CI, Viguerie N, Galitzky J, Decaunes P, Ricart W, Frühbeck G, Villarroya F, Mingrone G, Langin D, Zorzano A, Vidal H, Vendrell J, Burcelin R, Vidal-Puig A, Fernández-Real JM. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia. 2013 Nov;56(11):2524-37. doi: 10.1007/s00125-013-3015-9. Epub 2013 Aug 21. Domingo P, Mateo MG, Pruvost A, Torres F, Salazar J, Gutierrez MD; Ma Carmen Cabeza, Domingo JC, Fernandez I, Villarroya F, Vidal F, Baiget M, de la Calle-Martín O. Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients. PLoS One. 2013 Jun 26;8(6):e67035. Print 2013. Villarroya J, Cereijo R, Villarroya F. An endocrine role for brown adipose tissue? Am J Physiol Endocrinol Metab. 2013 Sep 1;305(5):E567-72. doi: 10.1152/ajpendo.00250.2013. Epub 2013 Jul 9. Review. Giralt M, Villarroya F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology. 2013 Sep;154(9):2992-3000. doi: 10.1210/en.2013-1403. Epub 2013 Jun 19. Review. Planavila A, Redondo I, Hondares E, Vinciguerra M, Munts C, Iglesias R, Gabrielli LA, Sitges M, Giralt M, van Bilsen M, Villarroya F. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat Commun. 2013;4:2019. doi: 10.1038/ncomms3019. Gallego-Escuredo JM, Villarroya J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya F, Giralt M. Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):142-8. doi: 10.1097/QAI.0b013e31829bdb67. De Sousa-Coelho AL, Relat J, Hondares E, Pérez-Martí A, Ribas F, Villarroya F, Marrero PF, Haro D. FGF21 mediates the lipid metabolism response to amino acid starvation.  J Lipid Res. 2013 Jul;54(7):1786-97. doi: 10.1194/jlr.M033415. Epub 2013 May 9. López-Erauskin J, Galino J, Ruiz M, Cuezva JM, Fabregat I, Cacabelos D, Boada J, Martínez J, Ferrer I, Pamplona R, Villarroya F, Portero-Otín M, Fourcade S, Pujol A. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Hum Mol Genet. 2013 Aug 15;22(16):3296-305. doi: 10.1093/hmg/ddt186. Epub 2013 Apr 20. Villarroya F, Vidal-Puig A. Beyond the sympathetic tone: the new brown fat activators. Cell Metab. 2013 May 7;17(5):638-43. doi: 10.1016/j.cmet.2013.02.020. Epub 2013 Apr 11. Review. Domingo P, Cabeza Mdel C, Torres F, Salazar J, Gutierrez Mdel M, Mateo MG, Martínez E, Domingo JC, Fernandez I, Villarroya F, Ribera E, Vidal F, Baiget M. Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy. PLoS One. 2013;8(2):e57347. doi: 10.1371/journal.pone.0057347. Epub 2013 Feb 28. Díaz-Delfín J, Domingo P, Giralt M, Villarroya F.Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation.Cytokine. 2013 Jan 25. Gallego-Escuredo JM, Domingo P, Fontdevila J, Villarroya J, Domingo JC, Martinez E, Giralt M, Villarroya F.Hypertrophied facial fat in an HIV-1-infected patient after autologous transplantation from 'buffalo hump' retains a partial brown fat-like molecular signature.Antivir Ther. 2013 Jan 23. Gallego-Escuredo JM, Domingo P, Gutiérrez Mdel M, Mateo MG, Cabeza MC, Fontanet A, Vidal F, Domingo JC, Giralt M, Villarroya F Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients. J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):527-34. Ghinis-Hozumi Y, Antaramian A, Villarroya F, Piña E, Mora O.Potential role of sirtuins in livestock production. Animal. 2013 Jan;7(1):101-8.

previous

next